"Das St. Marien Hospital - Klinikum Lünen ist mit seinen 16 Fachabteilungen und 592 Betten der größte Gesundheitsanbieter im Kreis Unna und eines der größten Krankenhäuser im östlichen Ruhrgebiet. Wir sind ein katholisches Krankenhaus und zugleich akademisches Lehrkrankenhaus der Universität Münster - Zuwendung zu Patienten und Angehörigen und Spitzenmedizin betrachten wir als unsere erklärten Aufgaben. Neben zehn weiteren Krankenhäusern zählt das St. Marien Hospital Lünen zur Kath. St. Paulus Gesellschaft. Darüber hinaus agieren unter dem Paulus-Dach vier Altenheime in Dortmund und Castrop-Rauxel und eine Jugendhilfe-Einrichtung in Dortmund. Die Kath. St. Paulus Gesellschaft zählt zu den größten katholischen Trägern in Nordrhein- Westfalen."

During the past decade, St.-Marien-Hospital GmbH conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St.-Marien-Hospital GmbH" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Biotronik SE & Co. KG" with 4 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St.-Marien-Hospital GmbH" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Biotronik, Inc." with 1 trials as a collaborator, "Clinical Trial Unit, University Hospital Basel, Switzerland" with 1 trials as a collaborator, "Guidant Corporation" with 1 trials as a collaborator and "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "St.-Marien-Hospital GmbH" are "Heart Failure" (6 trials), "Atrial Fibrillation" (2 trials), "Cardiovascular Disease" (2 trials), "Atrial Fibrillation (AF)" (1 trials) and "Bradyarrhythmia" (1 trials). Many other conditions were trialed in "St.-Marien-Hospital GmbH" in a lesser frequency.

Most popular intervention types in "St.-Marien-Hospital GmbH" are "Device" (11 trials), "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "ABSORB Scaffold" (1 trials), "BIOMONITOR III and BIOMONITOR IIIm" (1 trials) and "CRT-D implantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "St.-Marien-Hospital GmbH" are 19 trials for "All" genders.

Currently, there are NaN active trials in "St.-Marien-Hospital GmbH". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in St.-Marien-Hospital GmbH, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in St.-Marien-Hospital GmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".